PPARGC1A and Huntington disease: Recently, investigations on the ability of AMP-activated protein kinase (AMPK) to activate PGC-1alpha in brain, liver, brown adipose tissue (BAT) and muscle of HD transgenic mice strengthened the theory that impaired activation of PGC-1alpha plays an important role in the metabolic disturbances involved in the pathology of HD [20,21].